本頁面由Tiger Trade Technology Pte. Ltd.提供服務

Travere Therapeutics, Inc.

64.74
+1.261.98%
盤前64.990.2500+0.39%04:58 EDT
成交量:138.47萬
成交額:8,950.94萬
市值:61.02億
市盈率:-135.88
高:65.86
開:64.51
低:63.84
收:63.48
52周最高:68.73
52周最低:22.06
股本:9,426.11萬
流通股本:9,276.71萬
量比:0.87
換手率:1.49%
股息:- -
股息率:- -
每股收益(TTM):-0.4764
每股收益(LYR):-0.2864
淨資產收益率:-236.35%
總資產收益率:-3.73%
市淨率:248.86
市盈率(LYR):-226.09

資料載入中...

2022/03/21

重要事件披露

8-K - Current report
2022/03/11

重要事件披露

8-K - Current report
2022/03/09

[補充]招股説明書

FWP - Filing under Securities Act Rules 163/433 of free writing prospectuses
2022/03/09

[補充]招股説明書

FWP - Filing under Securities Act Rules 163/433 of free writing prospectuses
2022/02/24

重要事件披露

8-K - Current report
2022/02/24

年度報告

10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
2022/02/14

超過5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2022/02/14

超過5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2022/02/14

超過5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2022/02/14

超過5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2022/02/14

超過5%披露

SC 13G - Statement of acquisition of beneficial ownership by individuals
2022/02/10

超過5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2022/02/10

超過5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2022/01/10

重要事件披露

8-K - Current report
2022/01/06

重要事件披露

8-K - Current report
2021/12/22

重要事件披露

8-K - Current report
2021/12/15

重要事件披露

8-K - Current report
2021/10/29

季度報告

10-Q - Quarterly report [Sections 13 or 15(d)]
2021/10/28

重要事件披露

8-K - Current report
2021/10/12

重要事件披露

8-K - Current report